10.28
price down icon4.10%   -0.44
after-market Dopo l'orario di chiusura: 10.28
loading
Precedente Chiudi:
$10.72
Aprire:
$10.54
Volume 24 ore:
247.16K
Relative Volume:
0.82
Capitalizzazione di mercato:
$1.36B
Reddito:
$7.50M
Utile/perdita netta:
$-81.89M
Rapporto P/E:
0.1939
EPS:
53.0176
Flusso di cassa netto:
$-63.58M
1 W Prestazione:
-4.28%
1M Prestazione:
-26.26%
6M Prestazione:
+6.53%
1 anno Prestazione:
+97.31%
Intervallo 1D:
Value
$10.11
$10.54
Intervallo di 1 settimana:
Value
$10.11
$11.33
Portata 52W:
Value
$5.26
$22.00

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
Nome
Mesoblast Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
73
Name
Cinguettio
@Mesoblast
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
MESO's Discussions on Twitter

Confronta MESO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MESO
Mesoblast Ltd Adr
10.28 1.36B 7.50M -81.89M -63.58M 53.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-23 Downgrade Jefferies Buy → Hold
2024-09-24 Aggiornamento Maxim Group Hold → Buy
2024-08-29 Aggiornamento Jefferies Hold → Buy
2024-07-23 Aggiornamento Piper Sandler Neutral → Overweight
2023-08-31 Aggiornamento Jefferies Hold → Buy
2023-08-07 Downgrade Maxim Group Buy → Hold
2023-08-04 Downgrade Piper Sandler Overweight → Neutral
2023-08-04 Downgrade William Blair Outperform → Mkt Perform
2023-03-09 Iniziato William Blair Outperform
2022-12-06 Downgrade Jefferies Buy → Hold
2022-09-06 Iniziato Piper Sandler Overweight
2021-04-07 Aggiornamento Maxim Group Hold → Buy
2020-12-22 Downgrade Maxim Group Buy → Hold
2020-12-04 Downgrade Chardan Capital Markets Neutral → Sell
2020-10-22 Iniziato RBC Capital Mkts Sector Perform
2020-08-14 Reiterato Maxim Group Buy
2020-05-28 Reiterato H.C. Wainwright Buy
2019-01-31 Ripresa H.C. Wainwright Buy
2018-03-22 Downgrade Credit Suisse Neutral → Underperform
2018-02-28 Reiterato Cantor Fitzgerald Buy
2017-08-31 Iniziato Oppenheimer Outperform
2017-06-08 Iniziato Cantor Fitzgerald Buy
Mostra tutto

Mesoblast Ltd Adr Borsa (MESO) Ultime notizie

pulisher
Apr 16, 2025

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives - GlobeNewswire Inc.

Apr 16, 2025
pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 03, 2025

MESO Stock Surges 80% In A Month After FDA Approval Of GVHD Drug - Barchart

Jan 03, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

Investors: What’s The Real Deal With W & T Offshore Inc (NYSE: WTI) - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Do Analysts Think About Aspen Aerogels Inc’s (NYSE:ASPN) Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 30, 2024
pulisher
Dec 30, 2024

Petco Health and Wellness Co Inc (NASDAQ: WOOF): A Hidden Gem Despite Volatility - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 30, 2024

Here’s Why Lineage Cell Therapeutics Inc (AMEX: LCTX) Is An Attractive Investment Right Now - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

No Stopping Editas Medicine Inc (NASDAQ: EDIT)’s Stock Plunged? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Do Analysts Think About Therealreal Inc’s (NASDAQ:REAL) Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 26, 2024

What Awaits These 4 Biotech Stocks That More Than Doubled In 2024 - Barchart

Dec 26, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 26, 2024

Best Momentum Stocks to Buy for November 26th - Yahoo Finance

Nov 26, 2024
pulisher
Nov 21, 2024

Investors Heavily Search Sea Limited Sponsored ADR (SE): Here is What You Need to Know - Yahoo Finance

Nov 21, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 18, 2024

Mesoblast files annual report and meeting notice - Investing.com

Oct 18, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Oct 02, 2024

Mesoblast stock soars to 52-week high, hits $8.7 - Investing.com

Oct 02, 2024
pulisher
Sep 30, 2024

Mesoblast to raise $50m from top shareholder for product launch - Capital Brief

Sep 30, 2024
pulisher
Sep 24, 2024

What Makes Holcim Ltd Unsponsored ADR (HCMLY) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Sep 24, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024
pulisher
Feb 28, 2024

Sea Limited (SE) to Report Q4 Earnings: What's in Store? - Yahoo Finance

Feb 28, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Aug 31, 2023

Mesoblast Ltd receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Aug 31, 2023
pulisher
Nov 30, 2022

Australia stocks higher at close of trade; S&P/ASX 200 up 0.43% - Investing.com

Nov 30, 2022
pulisher
Mar 23, 2022

Philip R. Krause, M.D., Former FDA Deputy Chief For Vaccines, Joins Mesoblast Board - Barchart

Mar 23, 2022
pulisher
Oct 02, 2020

ASX dives as Trump tests COVID positive - The Australian

Oct 02, 2020

Mesoblast Ltd Adr Azioni (MESO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):